Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2010
10/28/2010US20100273813 Novel n-phenylacetamide inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
10/28/2010US20100273806 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
10/28/2010US20100273802 New purine derivatives having, in particular, anti-proliferative properties, and their biological uses
10/28/2010US20100273797 Alpha-ketoamides and derivatives thereof
10/28/2010US20100273793 6-ARYL/HETEROALKYLOXY BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, APPLICATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS c-MET INHIBITORS
10/28/2010US20100273781 Cxcr3 receptor antagonists
10/28/2010US20100273767 Modulators of 5-ht receptors and methods of use thereof
10/28/2010US20100273760 Topical Pharmaceutical Formulations And Methods Of Treatment
10/28/2010US20100273756 Adjunctive formulation and methods for palliation of fine wrinkles, mottled hyperpigmentation, tactile roughness of facial skin and related disorders
10/28/2010US20100273752 Mequitazine for treating or preventing pathologies involving histamine h4 receptors
10/28/2010US20100273750 Serotonin receptor antagonists for treating arthritis
10/28/2010US20100273748 Antimicrobial therapy
10/28/2010US20100273734 Derivatives of Hyaluronic Acids
10/28/2010US20100273729 Compositions Comprising Compounds Of Natural Origin For Damaged Skin
10/28/2010US20100273725 Novel compounds useful in therapeutic and cosmetic methods
10/28/2010US20100273717 Use of an Extract from the Vigna Aconitifolia Plant in a Cosmetic and/or Dermopharmaceutical Composition
10/28/2010US20100272839 Treatment of fatty scalp with a lysate of bifidobacterium species
10/28/2010US20100272833 Topical compositions for anti-aging and methods of using same
10/28/2010US20100272804 Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use
10/28/2010US20100272789 External medicine for treatment or prevention
10/28/2010US20100272783 Methods of Treating Infections of the Nail
10/28/2010US20100272768 Compositions and methods for cell killing
10/28/2010US20100272763 Skin external preparation and method of producing the same
10/28/2010US20100272756 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
10/28/2010US20100272754 Botulinum toxin administration to treat various conditions
10/28/2010US20100272735 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
10/28/2010US20100272733 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf)
10/28/2010US20100272731 Engineered anti-il-23p19 antibodies
10/28/2010US20100272726 Assays, methods and means
10/28/2010US20100272718 Antibodies Against Human NKG2D and Uses Thereof
10/28/2010US20100272716 Antibodies to VLA-1
10/28/2010US20100272708 Method for the treatment of type and type iv hypersensitivity
10/28/2010US20100272699 MC-1R, MC-2R, and/or µ OPIOID RECEPTORS STIMULATION
10/28/2010US20100272684 Hyperbaric treatment in wound healing
10/28/2010US20100272679 Compositions and methods of promoting wound healing
10/28/2010US20100272669 Freeze-Dried Composition
10/28/2010US20100272661 Process for the preparation of inverse latex of acrylamide-based polymers and composition comprising said latex
10/28/2010CA2760359A1 Compositions and methods for treating burns
10/28/2010CA2759730A1 Stable topical compositions for 1,2,4-thiadiazole derivatives
10/28/2010CA2759571A1 Two component interactive emulsion product
10/28/2010CA2758894A1 Novel thyroid hormone .beta. receptor agonist
10/28/2010CA2758571A1 Compositions containing hc-ha complex and methods of use thereof
10/27/2010EP2243771A2 Composition and method for promoting hair growth
10/27/2010EP2243483A1 Amlodipine salt compositions for topical application
10/27/2010EP2167016B1 Chitosan carboxyalkylamide hydrogel, preparation thereof and cosmetic and dermatological use thereof
10/27/2010EP1432408B1 Pharmaceutical compositions comprising colloidal silicon dioxide
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010CN1898231B Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
10/27/2010CN1678317B 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/27/2010CN1585640B N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
10/27/2010CN1585633B Phenethanolamine derivatives for treatment of respiratory diseases
10/27/2010CN101870974A Preparation method of proteinase activated receptors agonist and use thereof
10/27/2010CN101870945A Skin moisturizing, beautifying and health-care wine
10/27/2010CN101869668A Film coating agent for treating empyrosis and preparation method thereof
10/27/2010CN101869655A Quick-acting scarless burn and scald ointment
10/27/2010CN101869647A Method for preparing Chinese medicinal lotion for treating early plmar pustule
10/27/2010CN101869642A Chinese medicinal composition
10/27/2010CN101869639A Chinese medicinal decoction for treating acute radiodermatitis
10/27/2010CN101869636A Granulation-promoting paste with main components of sinkiang arnebia root and sesame oil
10/27/2010CN101869627A Medicament for treating empyrosis
10/27/2010CN101869626A Chinese medicinal compound preparation private care liquid, and preparation and application thereof
10/27/2010CN101869623A Medicament for treating trichoepithelioma and preparation method thereof
10/27/2010CN101869619A Medicament for treating tinea corporis and preparation method thereof
10/27/2010CN101869618A Chinese medicinal acne-removal mixture for treating acne
10/27/2010CN101869616A Hair nourishing liquid and manufacturing method thereof
10/27/2010CN101869615A Ointment for treating cheek erythema
10/27/2010CN101869614A Skin care and frostbite prevention cream and preparation method thereof
10/27/2010CN101869610A Wound medicament of acer truncatum essential oil
10/27/2010CN101869606A Method for preparing food-care essential oil
10/27/2010CN101869601A External veterinary medicament
10/27/2010CN101869584A Processing technique of tree sap fusion agent
10/27/2010CN101869578A External liniment for drawing pus out and diminishing inflammation
10/27/2010CN101869573A Aqueous solution of silybin glucoside and external composition for skin
10/27/2010CN101869541A Skin care product comprising plant extract and preparation method thereof
10/27/2010CN101322802B Paste for curing psoriasis and preparation thereof
10/27/2010CN101284124B Attapulgite alcohol group kibe formulations
10/27/2010CN101279092B Applications of VEGF receptor fusion protein in preparation of medicament for curing diseases about angiogenesis
10/27/2010CN101239128B Menstruation-regulating face-nourishing Chinese medicinal composition and preparation thereof
10/26/2010US7820819 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820722 Comprises a multi-carbon backbone having an at least partially neutralized carboxy or sulfonic functional group and also one or more side chains that have one or more carbon atoms and, optionally, one or more functional groups.
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820636 purine base or a salt thereof for preparing a promoter for saccharide uptake in epidermal keratinocytes
10/26/2010US7820199 for therapy of allergic and/or inflammatory conditions of the skin and airway passages; desloratadine-pseudoephedrine once-a-day product which produces a release rate profile for pseudoephedrine over an extended period in excess of twelve hours while maintaining delivery of desloratadine
10/26/2010US7820196 Alleviating acute alcohol intoxication/side effects of a hangover by administering, for example, 2,3-dimercapto-1-propanol; food additives/supplements; animal feed; oxidation resistance; immunostimulants; demetallization; shelf life cosmetology; dermatology; food additives/supplements; feeds; drugs
10/26/2010US7820178 VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agents
10/26/2010US7820170 monoclonal antibody exhibit antagonist activity of the anti-CD40 antibody; antiproliferative agents; controlling cell differentiation; anticarcinogenic agents; Hodgkin's disease, leukemias
10/26/2010US7820161 Treatment of autoimmune diseases
10/26/2010CA2543650C A crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing thesame
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2434608C Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent
10/26/2010CA2409221C Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
10/26/2010CA2398707C C1 inhibitor produced in the milk of transgenic mammals
10/21/2010WO2010121082A2 Emulsions of perfluorocarbons
10/21/2010WO2010120875A2 Treatment of skin damage
10/21/2010WO2010120691A2 Methionine sulfoxide peptide, compositions and methods of use
10/21/2010WO2010120374A2 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
10/21/2010WO2010120266A1 Hpv particles and uses thereof
10/21/2010WO2010120237A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
10/21/2010WO2010119955A1 Agent for preventing, inhibiting, or ameliorating skin aging due to buildup of advanced glycation end products